Biotech · Private company
NantBioScience, Inc.
Track this companyFree. Adds NantBioScience, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- AMG 479Phase 2 · Adenocarcinoma of the PancreasClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 2 · Adenocarcinoma of the PancreasClinicalTrials.gov · fetched Nov 12, 2026
- ABI-011Phase 1 · Neoplastic DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ETBX-021Phase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- YE-NEO-001Phase 1 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.PHASE1 · COMPLETED · started Aug 10, 2018ClinicalTrials.gov NCT03552718 · fetched Nov 12, 2026
- QUILT-3.014: A Trial of ABI-011 Administered Weekly in Patients With Advanced Solid Tumors or LymphomasPHASE1 · WITHDRAWN · started Nov 13, 2017ClinicalTrials.gov NCT02582827 · fetched Nov 12, 2026
- QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast CancerPHASE1 · TERMINATED · started Mar 4, 2017ClinicalTrials.gov NCT02751528 · fetched Nov 12, 2026
- Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the PancreasPHASE2 · TERMINATED · started May 31, 2012ClinicalTrials.gov NCT01318642 · fetched Nov 12, 2026